CAS: 362665-56-3; 1-(3-(3-(4-Chlorophenyl)Propoxy)Propyl)Piperidine

结构式图片

欧盟法规

C&L通报

上下游产品

3-(4'-氯苯基)丙醇 3-(P-Chlorophenyl)Propanol 6282-88-8
3-(4-氯苯基)丙酸 3-(4-Chlorophenyl)Propanoic Acid 2019-34-3

合成工艺路线路线简述

    📜哌啶置于sodium Tetrahydroborate体系中,用 四氢呋喃,甲醇,丙酮 作为反应溶剂,化学反应生成 Pitolisant; 1-[3-[3-(4-氯苯基)丙氧基]丙基]哌啶
    参考文献:使用季铵盐作为卤素源快速,通用地获得 α-卤代酮
    标题:使用季铵盐作为卤素源快速,通用地获得 α-卤代酮
    摘要:开发了一种以n-烯氧基吡啶鎓盐为底物,季铵盐为卤素源制备α-卤代酮的通用,快速,可规模化的方法,具有反应条件温和,官能团耐受性优异,反应时间短,适用范围广等特点.底物范围.
    DOI:10.1021/acs.Joc.3C02195

    海关参考信息

    专利信息


    专利号:US-9751877-B2
    优先权日:2012-09-21
    标题 :Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
    发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; PATEL NANDINI CHATURBHAI; STIFF CORY MICHAEL; TRAN TUAN PHONG; KAUFFMAN GREGORY WAYNE; STEPAN ANTONIA FRIEDERIKE; VERHOEST PATRICK ROBERT
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:IT-201900013941-A1
    优先权日:2019-08-05
    标 题 :PROCESS FOR THE SYNTHESIS OF PITOLISANT HCl

    专利号:WO-2012172449-A1
    优先权日:2011-06-13
    标题:Lactams as beta secretase inhibitors
    发明人:BRODNEY MICHAEL AARON
    权利人:PFIZER; BRODNEY MICHAEL AARON
    摘要:Compound and pharmaceutically acceptable salts of the compound are disclosed, wherein the compound has the structure (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. The compound of formula I is useful as beta secretase inhibitor for use in the treatment of Alzheimer's and other neurodegenerative and/or neurological disorders.

    专利号:US-2016229847-A1
    优先权日:2013-10-04
    标 题:Novel bicyclic pyridinones as gamma-secretase modulators
    发明人:PETTERSSON MARTIN YOUNGJIN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; JOHNSON DOUGLAS SCOTT; KAUFFMAN GREGORY WAYNE; O'DONNELL CHRISTOPHER WILLIAM; PATEL NANDINI CHATURBHAI; STEPAN ANTONIA FRIEDERIKE; STIFF CORY MICHAEL; SUBRAMANYAM CHAKRAPANI; TRAN TUAN PHONG; VERHOEST PATRICK ROBERT
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula II as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:US-9067934-B2
    优先权日:2011-03-31
    标题 :Bicyclic pyridinones
    发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; FISH BENJAMIN ADAM; GREEN MICHAEL ERIC; MULLINS PATRICK BRADLEY; STIFF CORY MICHAEL; TRAN TUAN PHONG; NAVARATNAM THAYALAN
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:US-9765073-B2
    优先权日:2015-02-03
    标 题 :Cyclopropabenzofuranyl pyridopyrazinediones
    发明人:PETTERSSON MARTIN YOUNGJIN; AM ENDE CHRISTOPHER WILLIAM; JOHNSON DOUGLAS SCOTT; KAUFFMAN GREGORY WAYNE; STEPAN ANTONIA FRIEDERIKE; VERHOEST PATRICK ROBERT
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nwherein X, R 1 , R 2a , R 2b , R 4a , R 4b , R 5a , R 5b , R 6 , R 7 , R 10 , R 11 , and y are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Bolin K, Niska PÅ, Pirhonen L, Wasling P, Landtblom AM. The cost-utility of pitolisant as narcolepsy treatment. Acta Neurol Scand. 2019 Dec 14. doi: 10.1111/ane.13202. [Epub ahead of print] Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study. Sleep. 2019 Oct 21;42(11). pii: zsz174. doi: 10.1093/sleep/zsz174.
    4: Fouque C, Martin R, Seguro F, Montastruc JL, de Canecaude C. Splenic Infarction in a Narcoleptic Patient Treated With Methylphenidate, Venlafaxine, and Pitolisant. Ann Pharmacother. 2019 Sep
    10:1060028019872795. doi: 10.1177/1060028019872795. [Epub ahead of print] doi: 10.1016/j.mehy.2019.109342. Epub 2019 Jul 30.

    合成参考文献


    参考文献:10.1021/jm1010644
    摘要:Cherian J, Choi I, Nayyar A, Manjunatha UH, Mukherjee T, Lee YS, Boshoff HI, Singh R, Ha YH, Goodwin M, Lakshminarayana SB, Niyomrattanakit P, Jiricek J, Ravindran S, Dick T, Keller TH, Dartois V, Barry CE. Structure–Activity Relationships of Antitubercular Nitroimidazoles. 3. Exploration of the Linker and Lipophilic Tail of ((S)-2-Nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-Amino PA-824). J. Med. Chem. 2011 Jul 26;54(16):5639–59. doi: 10.1021/jm1010644.
    参考文献:10.1007/s00415-011-6171-1
    摘要:Hartmann A, Worbe Y, Arnulf I. Increasing histamine neurotransmission in Gilles de la Tourette syndrome. J Neurol. 2012 Feb;259(2):375–6. doi: 10.1007/s00415-011-6171-1.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知